IRVING, Texas–(BUSINESS WIRE)–Vizient Group Senior Vice President, Pharmacy Solutions Dan Kistner will present at the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) Workshop, which is being held May 24-25, 2022. The two-day workshop will highlight the FDA’s work to develop a QMM rating program that will … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, by Service (Upstream, Downstream, Fill/Finish), by Product (Biologics), by Region and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global biopharmaceuticals contract manufacturing market size is expected to reach USD 27.3 billion by 2030, growing at a CAGR … [Read more…]
Program includes new podcast series of informative interviews with thought leaders and lessons from basic science through the continuum of drug development. SAN DIEGO–(BUSINESS WIRE)–n-Lorem, a nonprofit foundation, launches its patient advocacy initiative referred to as the ‘Patient Empowerment Program,’ with the release of its new podcast series. Through this program, n-Lorem hopes to foster … [Read more…]
Excellent safety continues to be observed in ongoing Phase 2a dose optimization study (OVX836-003) Phase 2a dose optimization study extended to elderly population cohort (OVX836-003) Additional Phase 2a trial combining OVX836 with conventional quadrivalent influenza vaccine (QIV) initiated with first participants enrolled in Australia (OVX836-004) LYON, France–(BUSINESS WIRE)–Osivax, a biopharmaceutical company developing vaccines to provide … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global blood plasma derivatives market reached a value of US$ 40.5 billion in 2021. Looking forward, the market is projected to reach a value of US$ 59.8 billion by 2027, exhibiting … [Read more…]
Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours LONDON & SANTIAGO DE COMPOSTELA, Spain–(BUSINESS WIRE)–SunRock Biopharma S.L. (“SunRock”), a biopharmaceutical company that is developing a portfolio of innovative bispecific antibodies to treat incurable cancer, and Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development … [Read more…]
SHENZHEN, China–(BUSINESS WIRE)–#award–FEELM, the flagship atomization tech brand belonging to SMOORE, today announced that it has been awarded Red Dot Awards for Product Design 2022 for 4 innovative atomization products, including the world’s thinnest ceramic coil vape pod solution FEELM Air, eco-friendly non-nicotine disposable e-cigarette, and anti-dust mouthpiece hygienic e-cigarette. By virtue of creative product … [Read more…]
NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. LONDON–(BUSINESS WIRE)–#asthma–NuvoAir’s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function … [Read more…]
BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announced the pricing of $210 million aggregate principal amount of 2.25% convertible senior notes due 2028 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of … [Read more…]
Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, today announced … [Read more…]
